Quest Diagnostics   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: New York NY United States (1967)
Status: No NME R&D (1967)

Organization Overview

First Clinical Trial
2010
NCT01236365
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Quest Diagnostics | Quest Diagnostics-Nichols Insitute | Quest Medical Imaging

Active Ingredients

Drugs in Phase 4 Trials (1)

potassium chloride (klor-con) (1 trial)

Drugs in Phase 3 Trials (4)

atorvastatin (lipitor) (1 trial)

senicapoc (1 trial)

sgm-101 (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 1 Trials (1)

tnt009 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Hemolytic (Phase 1)

Anemia, Hemolytic, Autoimmune (Phase 1)

Anemia, Hemolytic, Congenital (Phase 3)

Dehydration (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Hypercholesterolemia (Phase 3)

Kidney Failure, Chronic (Phase 1)

Pemphigoid, Bullous (Phase 1)

Rectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6